The global Tuberculosis Therapeutics market was valued at US$ 840.1 million in 2023 and is anticipated to reach US$ 1061 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.

Tuberculosis Therapeutics Market

Tuberculosis (TB) is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections show no symptoms, in which case it is known as latent tuberculosis.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Tuberculosis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Therapeutics.

Report Scope

The Tuberculosis Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tuberculosis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Tuberculosis Therapeutics Market Report

Report Metric	Details
Report Name	Tuberculosis Therapeutics Market
Accounted market size in 2023	US$ 840.1 million
Forecasted market size in 2030	US$ 1061 million
CAGR	2.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Isoniazid Rifampin Pyrazinamide Hydrazine Derivatives Miscellaneous Anti-Tubercular Drugs Ethambutol Others
Segment by Application	Hospital Pharmacy Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Aventis Pharmaceuticals, Sanofi -Aventis, Versapharma Incorporated, Sigma Pharmaceutical Pty, Novartis AG, Hoffmann-La Roche, Bayer Health Care
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tuberculosis Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Tuberculosis Therapeutics Market growing?

Ans: The Tuberculosis Therapeutics Market witnessing a CAGR of 2.9% during the forecast period 2024-2030.

What is the Tuberculosis Therapeutics Market size in 2030?

Ans: The Tuberculosis Therapeutics Market size in 2030 will be US$ 1061 million.

Who are the main players in the Tuberculosis Therapeutics Market report?

Ans: The main players in the Tuberculosis Therapeutics Market are Aventis Pharmaceuticals, Sanofi -Aventis, Versapharma Incorporated, Sigma Pharmaceutical Pty, Novartis AG, Hoffmann-La Roche, Bayer Health Care

What are the Application segmentation covered in the Tuberculosis Therapeutics Market report?

Ans: The Applications covered in the Tuberculosis Therapeutics Market report are Hospital, Pharmacy, Clinics, Others

What are the Type segmentation covered in the Tuberculosis Therapeutics Market report?

Ans: The Types covered in the Tuberculosis Therapeutics Market report are Isoniazid, Rifampin, Pyrazinamide, Hydrazine Derivatives, Miscellaneous Anti-Tubercular Drugs, Ethambutol, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tuberculosis Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Isoniazid

1.2.3 Rifampin

1.2.4 Pyrazinamide

1.2.5 Hydrazine Derivatives

1.2.6 Miscellaneous Anti-Tubercular Drugs

1.2.7 Ethambutol

1.2.8 Others

1.3 Market by Application

1.3.1 Global Tuberculosis Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Clinics

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tuberculosis Therapeutics Market Perspective (2019-2030)

2.2 Tuberculosis Therapeutics Growth Trends by Region

2.2.1 Global Tuberculosis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Tuberculosis Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Tuberculosis Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Tuberculosis Therapeutics Market Dynamics

2.3.1 Tuberculosis Therapeutics Industry Trends

2.3.2 Tuberculosis Therapeutics Market Drivers

2.3.3 Tuberculosis Therapeutics Market Challenges

2.3.4 Tuberculosis Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Tuberculosis Therapeutics Players by Revenue

3.1.1 Global Top Tuberculosis Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Tuberculosis Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Tuberculosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Tuberculosis Therapeutics Revenue

3.4 Global Tuberculosis Therapeutics Market Concentration Ratio

3.4.1 Global Tuberculosis Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Therapeutics Revenue in 2023

3.5 Tuberculosis Therapeutics Key Players Head office and Area Served

3.6 Key Players Tuberculosis Therapeutics Product Solution and Service

3.7 Date of Enter into Tuberculosis Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Tuberculosis Therapeutics Breakdown Data by Type

4.1 Global Tuberculosis Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Tuberculosis Therapeutics Forecasted Market Size by Type (2025-2030)

5 Tuberculosis Therapeutics Breakdown Data by Application

5.1 Global Tuberculosis Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Tuberculosis Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Tuberculosis Therapeutics Market Size (2019-2030)

6.2 North America Tuberculosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Tuberculosis Therapeutics Market Size by Country (2019-2024)

6.4 North America Tuberculosis Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Tuberculosis Therapeutics Market Size (2019-2030)

7.2 Europe Tuberculosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Tuberculosis Therapeutics Market Size by Country (2019-2024)

7.4 Europe Tuberculosis Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Tuberculosis Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Tuberculosis Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Tuberculosis Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Tuberculosis Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Tuberculosis Therapeutics Market Size (2019-2030)

9.2 Latin America Tuberculosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Tuberculosis Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Tuberculosis Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Tuberculosis Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Tuberculosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Tuberculosis Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Tuberculosis Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Aventis Pharmaceuticals

11.1.1 Aventis Pharmaceuticals Company Detail

11.1.2 Aventis Pharmaceuticals Business Overview

11.1.3 Aventis Pharmaceuticals Tuberculosis Therapeutics Introduction

11.1.4 Aventis Pharmaceuticals Revenue in Tuberculosis Therapeutics Business (2019-2024)

11.1.5 Aventis Pharmaceuticals Recent Development

11.2 Sanofi -Aventis

11.2.1 Sanofi -Aventis Company Detail

11.2.2 Sanofi -Aventis Business Overview

11.2.3 Sanofi -Aventis Tuberculosis Therapeutics Introduction

11.2.4 Sanofi -Aventis Revenue in Tuberculosis Therapeutics Business (2019-2024)

11.2.5 Sanofi -Aventis Recent Development

11.3 Versapharma Incorporated

11.3.1 Versapharma Incorporated Company Detail

11.3.2 Versapharma Incorporated Business Overview

11.3.3 Versapharma Incorporated Tuberculosis Therapeutics Introduction

11.3.4 Versapharma Incorporated Revenue in Tuberculosis Therapeutics Business (2019-2024)

11.3.5 Versapharma Incorporated Recent Development

11.4 Sigma Pharmaceutical Pty

11.4.1 Sigma Pharmaceutical Pty Company Detail

11.4.2 Sigma Pharmaceutical Pty Business Overview

11.4.3 Sigma Pharmaceutical Pty Tuberculosis Therapeutics Introduction

11.4.4 Sigma Pharmaceutical Pty Revenue in Tuberculosis Therapeutics Business (2019-2024)

11.4.5 Sigma Pharmaceutical Pty Recent Development

11.5 Novartis AG

11.5.1 Novartis AG Company Detail

11.5.2 Novartis AG Business Overview

11.5.3 Novartis AG Tuberculosis Therapeutics Introduction

11.5.4 Novartis AG Revenue in Tuberculosis Therapeutics Business (2019-2024)

11.5.5 Novartis AG Recent Development

11.6 Hoffmann-La Roche

11.6.1 Hoffmann-La Roche Company Detail

11.6.2 Hoffmann-La Roche Business Overview

11.6.3 Hoffmann-La Roche Tuberculosis Therapeutics Introduction

11.6.4 Hoffmann-La Roche Revenue in Tuberculosis Therapeutics Business (2019-2024)

11.6.5 Hoffmann-La Roche Recent Development

11.7 Bayer Health Care

11.7.1 Bayer Health Care Company Detail

11.7.2 Bayer Health Care Business Overview

11.7.3 Bayer Health Care Tuberculosis Therapeutics Introduction

11.7.4 Bayer Health Care Revenue in Tuberculosis Therapeutics Business (2019-2024)

11.7.5 Bayer Health Care Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Aventis Pharmaceuticals

Sanofi Aventis

Versapharma Incorporated

Sigma Pharmaceutical Pty

Novartis

Hoffmann La Roche

Bayer Health Care

List of Tables

Table 1. Global Tuberculosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Isoniazid

Table 3. Key Players of Rifampin

Table 4. Key Players of Pyrazinamide

Table 5. Key Players of Hydrazine Derivatives

Table 6. Key Players of Miscellaneous Anti-Tubercular Drugs

Table 7. Key Players of Ethambutol

Table 8. Key Players of Others

Table 9. Global Tuberculosis Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Tuberculosis Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Tuberculosis Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 12. Global Tuberculosis Therapeutics Market Share by Region (2019-2024)

Table 13. Global Tuberculosis Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 14. Global Tuberculosis Therapeutics Market Share by Region (2025-2030)

Table 15. Tuberculosis Therapeutics Market Trends

Table 16. Tuberculosis Therapeutics Market Drivers

Table 17. Tuberculosis Therapeutics Market Challenges

Table 18. Tuberculosis Therapeutics Market Restraints

Table 19. Global Tuberculosis Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 20. Global Tuberculosis Therapeutics Market Share by Players (2019-2024)

Table 21. Global Top Tuberculosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Therapeutics as of 2023)

Table 22. Ranking of Global Top Tuberculosis Therapeutics Companies by Revenue (US$ Million) in 2023

Table 23. Global 5 Largest Players Market Share by Tuberculosis Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 24. Key Players Headquarters and Area Served

Table 25. Key Players Tuberculosis Therapeutics Product Solution and Service

Table 26. Date of Enter into Tuberculosis Therapeutics Market

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Tuberculosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 29. Global Tuberculosis Therapeutics Revenue Market Share by Type (2019-2024)

Table 30. Global Tuberculosis Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 31. Global Tuberculosis Therapeutics Revenue Market Share by Type (2025-2030)

Table 32. Global Tuberculosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 33. Global Tuberculosis Therapeutics Revenue Market Share by Application (2019-2024)

Table 34. Global Tuberculosis Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 35. Global Tuberculosis Therapeutics Revenue Market Share by Application (2025-2030)

Table 36. North America Tuberculosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Tuberculosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Tuberculosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Tuberculosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. Europe Tuberculosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 41. Europe Tuberculosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 42. Asia-Pacific Tuberculosis Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 43. Asia-Pacific Tuberculosis Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 44. Asia-Pacific Tuberculosis Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 45. Latin America Tuberculosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Latin America Tuberculosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 47. Latin America Tuberculosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 48. Middle East & Africa Tuberculosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 49. Middle East & Africa Tuberculosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 50. Middle East & Africa Tuberculosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 51. Aventis Pharmaceuticals Company Detail

Table 52. Aventis Pharmaceuticals Business Overview

Table 53. Aventis Pharmaceuticals Tuberculosis Therapeutics Product

Table 54. Aventis Pharmaceuticals Revenue in Tuberculosis Therapeutics Business (2019-2024) & (US$ Million)

Table 55. Aventis Pharmaceuticals Recent Development

Table 56. Sanofi -Aventis Company Detail

Table 57. Sanofi -Aventis Business Overview

Table 58. Sanofi -Aventis Tuberculosis Therapeutics Product

Table 59. Sanofi -Aventis Revenue in Tuberculosis Therapeutics Business (2019-2024) & (US$ Million)

Table 60. Sanofi -Aventis Recent Development

Table 61. Versapharma Incorporated Company Detail

Table 62. Versapharma Incorporated Business Overview

Table 63. Versapharma Incorporated Tuberculosis Therapeutics Product

Table 64. Versapharma Incorporated Revenue in Tuberculosis Therapeutics Business (2019-2024) & (US$ Million)

Table 65. Versapharma Incorporated Recent Development

Table 66. Sigma Pharmaceutical Pty Company Detail

Table 67. Sigma Pharmaceutical Pty Business Overview

Table 68. Sigma Pharmaceutical Pty Tuberculosis Therapeutics Product

Table 69. Sigma Pharmaceutical Pty Revenue in Tuberculosis Therapeutics Business (2019-2024) & (US$ Million)

Table 70. Sigma Pharmaceutical Pty Recent Development

Table 71. Novartis AG Company Detail

Table 72. Novartis AG Business Overview

Table 73. Novartis AG Tuberculosis Therapeutics Product

Table 74. Novartis AG Revenue in Tuberculosis Therapeutics Business (2019-2024) & (US$ Million)

Table 75. Novartis AG Recent Development

Table 76. Hoffmann-La Roche Company Detail

Table 77. Hoffmann-La Roche Business Overview

Table 78. Hoffmann-La Roche Tuberculosis Therapeutics Product

Table 79. Hoffmann-La Roche Revenue in Tuberculosis Therapeutics Business (2019-2024) & (US$ Million)

Table 80. Hoffmann-La Roche Recent Development

Table 81. Bayer Health Care Company Detail

Table 82. Bayer Health Care Business Overview

Table 83. Bayer Health Care Tuberculosis Therapeutics Product

Table 84. Bayer Health Care Revenue in Tuberculosis Therapeutics Business (2019-2024) & (US$ Million)

Table 85. Bayer Health Care Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Tuberculosis Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Tuberculosis Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Isoniazid Features

Figure 4. Rifampin Features

Figure 5. Pyrazinamide Features

Figure 6. Hydrazine Derivatives Features

Figure 7. Miscellaneous Anti-Tubercular Drugs Features

Figure 8. Ethambutol Features

Figure 9. Others Features

Figure 10. Global Tuberculosis Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 11. Global Tuberculosis Therapeutics Market Share by Application: 2023 VS 2030

Figure 12. Hospital Case Studies

Figure 13. Pharmacy Case Studies

Figure 14. Clinics Case Studies

Figure 15. Others Case Studies

Figure 16. Tuberculosis Therapeutics Report Years Considered

Figure 17. Global Tuberculosis Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 18. Global Tuberculosis Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Tuberculosis Therapeutics Market Share by Region: 2023 VS 2030

Figure 20. Global Tuberculosis Therapeutics Market Share by Players in 2023

Figure 21. Global Top Tuberculosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Therapeutics as of 2023)

Figure 22. The Top 10 and 5 Players Market Share by Tuberculosis Therapeutics Revenue in 2023

Figure 23. North America Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. North America Tuberculosis Therapeutics Market Share by Country (2019-2030)

Figure 25. United States Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Tuberculosis Therapeutics Market Share by Country (2019-2030)

Figure 29. Germany Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Tuberculosis Therapeutics Market Share by Region (2019-2030)

Figure 37. China Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Japan Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. South Korea Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. India Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Australia Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Tuberculosis Therapeutics Market Share by Country (2019-2030)

Figure 45. Mexico Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Brazil Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Tuberculosis Therapeutics Market Share by Country (2019-2030)

Figure 49. Turkey Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Aventis Pharmaceuticals Revenue Growth Rate in Tuberculosis Therapeutics Business (2019-2024)

Figure 52. Sanofi -Aventis Revenue Growth Rate in Tuberculosis Therapeutics Business (2019-2024)

Figure 53. Versapharma Incorporated Revenue Growth Rate in Tuberculosis Therapeutics Business (2019-2024)

Figure 54. Sigma Pharmaceutical Pty Revenue Growth Rate in Tuberculosis Therapeutics Business (2019-2024)

Figure 55. Novartis AG Revenue Growth Rate in Tuberculosis Therapeutics Business (2019-2024)

Figure 56. Hoffmann-La Roche Revenue Growth Rate in Tuberculosis Therapeutics Business (2019-2024)

Figure 57. Bayer Health Care Revenue Growth Rate in Tuberculosis Therapeutics Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Hepatitis A immunoglobulin Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-17D12859

Thu Jul 25 00:00:00 UTC 2024

Add to Cart

Global MRSA Antibiotic Preparations Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-5H7703

Wed Jul 24 00:00:00 UTC 2024

Add to Cart

Global Novel Coronavirus (COVID-19) Vaccine Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-29K5790

Fri Jul 19 00:00:00 UTC 2024

Add to Cart

Global Specific Antiviral Drugs for COVID-19 Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-3O6238

Fri Jul 19 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions